医药冷链 : 第三方物流尴尬的两难

医药冷链 : 第三方物流尴尬的两难

震惊全国的山东疫苗案——案值5.7亿元的疫苗未经严格的冷链运输就销往全国24个省份,将中国医药冷链物流的脆弱本质暴露无遗。这给整个行业敲响了警钟。由是,医药行业开始更加重视冷链物流。

然而,医药冷链物流要想驶入发展快车道,还需要突破一些两难境地。

Biopharma cold chain has re-gained attention in China after the vaccine incident in Shandong that $90 million worth of incorrectly handled vaccines were distributed in multiple provinces around the country. Though passing the deadline of complying with the revised GSP in 2015, it’s clear that the the quality and governance of biopharma cold chain process in China is still below expectation.


Please note: That all fields marked with an asterisk (*) are required.